George R. Breese

Q: What Schools Are Affiliated With George R. Breese

George R. Breese is affiliated with the following schools: University of North Carolina at Chapel Hill, Duke University

George R. Breese's AcademicInfluence.com Rankings

George R. Breese

Philosophy

#3768

World Rank

#6032

Historical Rank

Logic

#1390

World Rank

#2133

Historical Rank

philosophy Degrees

George R. Breese

Biology

#4764

World Rank

#7068

Historical Rank

Neuroscience

#517

World Rank

#537

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

George R. Breese's Degrees

PhD Neuroscience Stanford University
Doctorate Medicine Stanford University

Why Is George R. Breese Influential?

(Suggest an Edit or Addition)

(See a Problem?)

George R. Breese's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration (2007) (1792)
Depletion of brain noradrenaline and dopamine by 6‐hydroxydopamine (1971) (532)
Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons. (1970) (518)
Effects of thyrotropin-releasing hormone in depression. (1972) (512)
Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector (1996) (465)
Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. (1983) (363)
Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. (1991) (351)
Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite. (1968) (350)
Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety (1996) (326)
Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. (1984) (299)
Effects of ethanol on ion channels. (1996) (298)
Effects of thyrotropin-releasing hormone (TRH) on the actions of pentobarbital and other centrally acting drugs. (1975) (292)
Thyrotropin Releasing Hormone: Enhancement of Dopa Activity by a Hypothalamic Hormone (1972) (270)
Selective release of newly synthesized norepinephrine from the cat spleen during sympathetic nerve stimulation. (1968) (239)
Stress enhancement of craving during sobriety: a risk for relapse. (2005) (235)
Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. (1996) (231)
Pharmacokinetics of methylphenidate in man, rat and monkey. (1983) (227)
Self-injurious behavior: gene-brain-behavior relationships. (2001) (225)
Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse. (2011) (223)
3-methoxy-4-hydroxyphenylglycol sulfate in brain and cerebrospinal fluid. (1968) (221)
Ontogeny of D1a and D2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding (1994) (214)
6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. (1987) (213)
Thydrotropin releasing hormone: antagonism of pentobarbital in rodents. (1974) (212)
Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6‐hydroxydopamine (1972) (207)
Analysis of the disruption in hypothalamic-pituitary regulation in rats treated neonatally with monosodium L-glutamate (MSG): evidence for the involvement of tuberoinfundibular cholinergic and dopaminergic systems in neuroendocrine regulation. (1977) (206)
Growth and behavioral changes in developing rats treated intracisternally with 6-hydroxydopamine: evidence for involvement of brain dopamine. (1973) (199)
Pharmacology of the enantiomers of threo-methylphenidate. (1987) (194)
Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies. (1983) (186)
Characterization of susceptibility to audiogenic seizures in ethanol-dependent rats after microinjection of gamma-aminobutyric acid (GABA) agonists into the inferior colliculus, substantia nigra or medial septum. (1983) (182)
Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors (2004) (174)
Behavioral and biochemical interactions of 5,7-dihydroxy-tryptamine with various drugs when administered intracisternally to adult and developing rats (1975) (169)
Simultaneous quantification of dopamine, 5-hydroxytryptamine and four metabolically related compounds by means of reversed-phase high-performance liquid chromatography with electrochemical detection. (1981) (167)
Antagonism of ethanol narcosis by thyrotropin releasing hormone. (1974) (166)
Accentuated decrease in social interaction in rats subjected to repeated ethanol withdrawals. (2002) (164)
EVIDENCE FOR INVOLVEMENT OF 5‐HYDROXYTRYPTAMINE IN THE ACTIONS OF AMPHETAMINE (1974) (163)
Conceptual framework for the etiology of alcoholism: a “kindling”/stress hypothesis (2005) (162)
Molecular basis for regionally specific action of ethanol on gamma-aminobutyric acidA receptors: generalization to other ligand-gated ion channels. (1993) (160)
Preparative methods for brain slices: a discussion (1995) (153)
The neuropharmacology of respiratory control. (1982) (151)
Genetic essential tremor in ?-aminobutyric acidA receptor a1 subunit knockout mice (2005) (150)
Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine. (1985) (150)
Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats. (1985) (149)
Ethanol inhibits NMDA-evoked electrophysiological activity in vivo. (1991) (148)
Electrically elicited seizures from the inferior colliculus: A potential site for the genesis of epilepsy? (1984) (148)
Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine. (1973) (148)
Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment. (1982) (147)
Multiple withdrawals from chronic ethanol "kindles" inferior collicular seizure activity: evidence for kindling of seizures associated with alcoholism. (1990) (142)
Clinical studies of methylphenidate serum levels in children and adults. (1982) (140)
GABAergic modulation of ethanol-induced motor impairment. (1982) (136)
SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats. (2004) (135)
Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action. (1967) (132)
Neurotensin-induced hypothermia: Evidence for an interaction with dopaminergic systems and the hypothalamic-pituitary-thyroids axis (1980) (130)
An inhibitory role for brain serotonin-containing systems in the locomotor effects of d-amphetamine. (1976) (130)
Prior Multiple Ethanol Withdrawals Enhance Stress-Induced Anxiety-Like Behavior: Inhibition by CRF1- and Benzodiazepine-Receptor Antagonists and a 5-HT1a-Receptor Agonist (2005) (127)
Neonatal and Adult 6‐Hydroxydopamine‐Induced Lesions Differentially Alter Tachykinin and Enkephalin Gene Expression (1987) (126)
Inhibition of NMDA-evoked electrophysiological activity by ethanol in selected brain regions: evidence for ethanol-sensitive and ethanol-insensitive NMDA-evoked responses (1993) (122)
Site-specific enhancement of gamma-aminobutyric acid-mediated inhibition of neural activity by ethanol in the rat medial septal area. (1990) (119)
Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia (1998) (119)
Functional classification of antidepressants based on antagonism of swim stress-induced fos-like immunoreactivity. (1996) (113)
Investigations into the mechanism of reduction of ethanol sleep by thyrotropin-releasing hormone (TRH). (1976) (113)
Principles of pharmacology : basic concepts and clinical applications (1995) (112)
A Conceptualization of Integrated Actions of Ethanol Contributing to its GABAmimetic Profile: A Commentary (2005) (109)
Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice. (2005) (109)
Serotonergic innervation of the rat caudate following a neonatal 6-hydroxydopamine lesion: An anatomical, biochemical and pharmacological study (1989) (108)
Differential sensitivity of ethanol withdrawal signs in the rat to gamma-aminobutyric acid (GABA)mimetics: blockade of audiogenic seizures but not forelimb tremors. (1983) (107)
Corticotropin-Releasing Factor (CRF) Sensitization of Ethanol Withdrawal-Induced Anxiety-Like Behavior is Brain Site Specific and Mediated by CRF-1 Receptors: Relation to Stress-Induced Sensitization (2010) (106)
Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine. (1987) (104)
SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons. (1985) (104)
Increase in dopamine metabolites in rat brain by neurotensin. (1982) (103)
Induction of Fos-like proteins and ultrasonic vocalizations during ethanol withdrawal: further evidence for withdrawal-induced anxiety. (1998) (101)
Neonatal-6-hydroxydopamine treatment: Model of susceptibility for self-mutilation in the lesch-nyhan syndrome (1984) (101)
The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles (2005) (101)
Influence of cholecystokinin on central monoaminergic pathways (1983) (99)
An evaluation of the locomotor stimulating action of ethanol in rats and mice (2004) (92)
Flumazenil blockade of anxiety following ethanol withdrawal in rats (1997) (88)
GABAergic modulation of inferior colliculus excitability: role in the ethanol withdrawal audiogenic seizures. (1986) (88)
Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats. (1993) (88)
Serotonin and dopamine: distribution and accumulation in Aplysia nervous and non-nervous tissues. (1971) (88)
Baclofen blocks expression and sensitization of anxiety-like behavior in an animal model of repeated stress and ethanol withdrawal. (2007) (87)
A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats (2003) (85)
Effects of acute and chronic 1,3-butanediol treatment on central nervous system function: a comparison with ethanol. (1981) (85)
Alterations in consummatory behavior following intracisternal injection of 6-hydroxydopamine. (1973) (82)
Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone. (1998) (82)
Electrophysiological evidence that ethanol alters function of medial septal area without affecting lateral septal function. (1990) (81)
Evidence for a selective effect of ethanol on N-methyl-d-aspartate responses: ethanol affects a subtype of the ifenprodil-sensitive N-methyl-d-aspartate receptors. (1996) (80)
Effect of 6‐hydroxydopamine on electrical self stimulation of the brain (1971) (80)
Stress Sensitization of Ethanol Withdrawal-Induced Reduction in Social Interaction: Inhibition by CRF-1 and Benzodiazepine Receptor Antagonists and a 5-HT1A-Receptor Agonist (2004) (80)
Distribution of [3H]zolpidem binding sites in relation to messenger RNA encoding the α1, β2 and γ2 subunits of GABAA receptors in rat brain (1995) (77)
Ethanol-enhanced GABA release: A focus on G protein-coupled receptors (2011) (76)
Nicotine-induced inhibition in medial septum involves activation of presynaptic nicotinic cholinergic receptors on gamma-aminobutyric acid-containing neurons. (1996) (76)
Effects of thyrotropin-releasing hormone on locomotor activity, operant performance and ingestive behavior. (1979) (73)
Role of monoamine neural systems in L-dihydroxyphenylalanine-stimulated activity. (1979) (72)
Stress Sensitization of Ethanol Withdrawal-Induced Reduction in Social Interaction: Inhibition by CRF-1 and Benzodiazepine Receptor Antagonists and a 5-HT1A–Receptor Agonist (2004) (72)
Chemical and Immunochemical Lesions by Specific Neurotoxic Substances and Antisera (1975) (72)
Adeno-associated virus (AAV) vector antisense gene transfer in vivo decreases GABAA α 1 containing receptors and increases inferior collicular seizure sensitivity (1997) (71)
Calcium Release from Presynaptic Internal Stores Is Required for Ethanol to Increase Spontaneous γ-Aminobutyric Acid Release onto Cerebellum Purkinje Neurons (2007) (71)
Effect of zolpidem on gamma-aminobutyric acid (GABA)-induced inhibition predicts the interaction of ethanol with GABA on individual neurons in several rat brain regions. (1995) (70)
Serotonin Release from Brain Slices by Electrical Stimulation: Regional Differences and Effect of LSD (1967) (70)
Therapeutic liabilities of in vivo viral vector tropism: adeno-associated virus vectors, NMDAR1 antisense, and focal seizure sensitivity. (2002) (69)
Basis of the gabamimetic profile of ethanol. (2006) (69)
Alteration of avoidance and ingestive behavior after destruction of central catecholamine pathways with 6-hydroxydopamine. (1974) (68)
Synthesis and pharmacology of hydroxylated metabolites of methylphenidate. (1981) (68)
Peptides and the Central Nervous System (1978) (67)
Corticotropin‐releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat (1994) (67)
Enhancement of ethanol-induced sedation and hypothermia by centrally administered neurotensin, β-endorphin and bombesin (1981) (67)
Long-term D1-dopamine receptor sensitization in neonatal 6-OHDA-lesioned rats is blocked by an NMDA antagonist (1990) (67)
A dopamine deficiency model of Lesch-Nyhan disease—the neonatal-6-OHDA-lesioned rat (1990) (67)
Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness (2002) (67)
The cytokine mRNA increase induced by withdrawal from chronic ethanol in the sterile environment of brain is mediated by CRF and HMGB1 release. (2013) (66)
Effects of antidepressant drugs injected into the amygdala on behavioral responses of rats in the forced swim test. (1986) (66)
Biochemical and behavioural alterations following 5,6-dihydroxytryptamine administration into brain. (1974) (66)
Modification of pentobarbital effects by natural and synthetic polypeptides: dissociation of brain and pituitary effects. (1975) (65)
Repeated Lipopolysaccharide (LPS) or Cytokine Treatments Sensitize Ethanol Withdrawal-Induced Anxiety-Like Behavior (2008) (64)
Rapid down regulation of beta adrenergic receptors by combining antidepressant drugs with forced swim: a model of antidepressant-induced neural adaptation. (1985) (64)
The effect of drugs which alter GABA-ergic function on cerebellar guanosine-3',5'-monophosphate content. (1978) (63)
Sensitivity to ethanol across development in rats: comparison to [3H]zolpidem binding. (1998) (63)
The CRF-1 receptor antagonist, CP-154,526, attenuates stress-induced increases in ethanol consumption by BALB/cJ mice. (2008) (63)
Thyroid-imipramine clinical and chemical interaction: evidence for a receptor deficit in depression. (1972) (63)
Supersensitivity to the respiratory stimulatory effect of TRH in 5,7-dihydroxytryptamine-treated rats (1984) (62)
Effects of melanocortin receptor activation and blockade on ethanol intake: a possible role for the melanocortin-4 receptor. (2005) (61)
Autoradiographic characterization of [3H]imipramine and [3H]citalopram binding in rat and human brain: species differences and relationships to serotonin innervation patterns (1992) (61)
Sensitization, duration, and pharmacological blockade of anxiety-like behavior following repeated ethanol withdrawal in adolescent and adult rats. (2009) (61)
Metabolism of some phenylethylamines and their beta-hydroxylated analogs in brain. (1969) (61)
Regional specificity of ethanol and NMDA action in brain revealed with FOS-like immunohistochemistry and differential routes of drug administration. (2001) (61)
Effects of psychoactive drugs on the metabolism of intracisternally administered serotonin in rat brain. (1969) (60)
Thyrotropin releasing hormone: enhancement of DOPA activity in thyroidectomized rats. (1974) (59)
Evaluation of the effects of nerve growth factor and anti-nerve growth factor on the development of central catecholamine-containing neurons (1978) (59)
Comparison of Effect of Ethanol onN-Methyl-d-aspartate- and GABA-Gated Currents from Acutely Dissociated Neurons: Absence of Regional Differences in Sensitivity to Ethanol (2003) (59)
[125I]RTI‐55 Binding to Cocaine‐Sensitive Dopaminergic and Serotonergic Uptake Sites in the Human Brain (1993) (59)
Possible mechanisms of reduction of plasma luteinizing hormone by ethanol. (1980) (59)
Metabolic and functional mapping of the neural network subserving inferior collicular seizure generalization (1995) (59)
Reduction in repeated ethanol-withdrawal-induced anxiety-like behavior by site-selective injections of 5-HT1A and 5-HT2C ligands (2006) (58)
Influence of Age and Strain on Striatal Dopamine Loss in a Genetic Mouse Model of Lesch‐Nyhan Disease (1999) (58)
Cytokine involvement in stress may depend on corticotrophin releasing factor to sensitize ethanol withdrawal anxiety (2011) (58)
A biochemical and morphological study of the altered growth pattern of central catecholamine neurons following 6-hydroxydopamine (1978) (57)
Effect of central catecholamine alterations by 6-hydroxydopamine on shuttle box avoidance acquistion. (1972) (57)
Comparison of basal neuropeptide Y and corticotropin releasing factor levels between the high ethanol drinking C57BL/6J and low ethanol drinking DBA/2J inbred mouse strains. (2005) (56)
Clinical Correlates of Methylphenidate Blood Levels (1984) (56)
An evaluation of the mechanism by which serotonergic activation depresses respiration. (1980) (56)
Effects of dopaminergic agonists and antagonists on cerebellar guanosine-3',5'-monophosphate (cGMP). (1978) (55)
The role of protein kinase A in the ethanol-induced increase in spontaneous GABA release onto cerebellar Purkinje neurons. (2008) (54)
Similar anxiety-like responses in male and female rats exposed to repeated withdrawals from ethanol (2004) (54)
Drug challenges reveal differences in mediation of stress facilitation of voluntary alcohol drinking and withdrawal-induced anxiety in alcohol-preferring P rats. (2007) (53)
BIOCHEMICAL AND BEHAVIOURAL ALTERATIONS FOLLOWING 6-HYDROXYDOPAMINE ADMINISTRATION INTO BRAIN. (1973) (53)
Repeated Lipopolysaccharide (LPS) or Cytokine Treatments Sensitize Ethanol Withdrawal-Induced Anxiety-Like Behavior (2008) (53)
Ethanol potentiates gamma-aminobutyric acid-mediated inhibition in the inferior colliculus: evidence for local ethanol/gamma-aminobutyric acid interactions. (1991) (53)
Codepletion of serotonin and TRH induces apparent supersensitivity of spinal TRH receptors. (1983) (52)
Differential modulation of GABA- and NMDA-gated currents by ethanol and isoflurane in cultured rat cerebral cortical neurons (2001) (52)
Induction of adrenal catecholamine synthesising enzymes following mother-infant separation. (1973) (51)
Distribution of methylphenidate and p-hydroxymethylphenidate in rats. (1984) (51)
Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling, rat strain and amine uptake. (1990) (51)
Developmental variations in CSF monoamine metabolites during childhood. (1986) (51)
The roles of monoamine neural systems in the anorexia induced by (+)-amphetamine and related compounds (1975) (49)
Regionally specific neural adaptation of beta adrenergic and 5-hydroxytryptamine2 receptors after antidepressant administration in the forced swim test and after chronic antidepressant drug treatment. (1988) (49)
Modification of the actions of ethanol by centrally active peptides (1981) (48)
Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine. (1978) (48)
The alcohol deprivation effect in C57BL/6J mice is observed using operant self-administration procedures and is modulated by CRF-1 receptor signaling. (2009) (48)
SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons. (1986) (47)
Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity. (1992) (46)
Inferior Collicular Interactions with Limbic Seizure Activity (1987) (46)
Thyrotropin releasing hormone: antagonism of pentobarbital narcosis in the monkey (1976) (46)
Modification of pentobarbital-induced sedation by natural and synthetic peptides (1978) (46)
Brain Regional Differences in the Effect of Ethanol on GABA Release from Presynaptic Terminals (2008) (45)
Dopaminergic interaction with the respiratory control system in the rat. (1979) (45)
Neurobiology of Central D1-Dopamine Receptors (1986) (45)
Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. (2002) (45)
Assessment of purine-dopamine interactions in 6-hydroxydopamine-lesioned rats: evidence for pre- and postsynaptic influences by adenosine. (1988) (44)
Effects of thioridazine and its metabolites on dopaminergic function: drug metabolism as a determinant of the antidopaminergic actions of thioridazine. (1984) (44)
Sustained Extracellular Signal-Regulated Kinase 1/2 Phosphorylation in Neonate 6-Hydroxydopamine-Lesioned Rats after Repeated D1-Dopamine Receptor Agonist Administration: Implications for NMDA Receptor Involvement (2004) (44)
Neurobiology of D1 dopamine receptors after neonatal-6-OHDA treatment: relevance to Lesch-Nyhan disease. (1986) (43)
Enhanced ultrasonic vocalization and Fos protein expression following ethanol withdrawal: effects of flumazenil (2000) (43)
Comparison of the CNS effects induced by TRH and bicuculline after microinjection into medial septum, substantia nigra and inferior colliculus: Absence of support for a GABA antagonist action for TRH (1984) (43)
Interactions of stress and CRF in ethanol-withdrawal induced anxiety in adolescent and adult rats. (2010) (42)
Modulation of ethanol withdrawal-induced anxiety-like behavior during later withdrawals by treatment of early withdrawals with benzodiazepine/gamma-aminobutyric acid ligands. (2005) (42)
Erythrosine (Red No. 3) and its nonspecific biochemical actions: what relation to behavioral changes? (1980) (41)
A potential contribution to ethanol withdrawal kindling: reduced GABA function in the inferior collicular cortex. (1993) (41)
Central actions of 6-hydroxydopamine and other phenylethylamine derivatives on body temperature in the rat. (1972) (40)
Role of carotid body catecholamines in chemoreceptor function (1978) (40)
Dopamine deficiency in self-injurious behavior. (1989) (40)
β-Adrenergic receptor distribution in human and rat hippocampal formation: marked species differences (1991) (39)
Predictors of high ethanol consumption in RIIbeta knock-out mice: assessment of anxiety and ethanol-induced sedation. (2004) (39)
Competing presynaptic and postsynaptic effects of ethanol on cerebellar purkinje neurons. (2006) (39)
The absorption of sustained‐release methylphenidate formulations compared to an immediate‐release formulation (1989) (39)
Decreased Immunoreactivity of the Melanocortin Neuropeptide α-Melanocyte-Stimulating Hormone (α-MSH) After Chronic Ethanol Exposure in Sprague–Dawley Rats (2008) (37)
Effects of ethanol, chlordiazepoxide, and MK-801 on performance in the elevated-plus maze and on locomotor activity. (1994) (37)
Central Monaminergic Neuronal Effects on Minimum Alveolar Concentrations (MAC) of Halothane and Cyclopropane in Rats (1975) (37)
Nerve growth factor (NGF) has novel antidepressant-like properties in rats (2010) (37)
SUBNORMAL CSF LEVELS OF NEUROTENSIN IN A SUBGROUP OF SCHIZOPHRENICS AND NORMALIZATION AFTER NEUROLEPTIC TREATMENT (1982) (37)
Stress and Withdrawal from Chronic Ethanol Induce Selective Changes in Neuroimmune mRNAs in Differing Brain Sites (2016) (36)
The amygdala regulates the antianxiety sensitization effect of flumazenil during repeated chronic ethanol or repeated stress. (2007) (36)
Differential dietary ethanol intake and blood ethanol levels in adolescent and adult rats: effects on anxiety-like behavior and seizure thresholds. (2008) (35)
The PLC/IP3R/PKC pathway is required for ethanol-enhanced GABA release (2010) (34)
Behavioral and biochemical assessment of time-related changes in globus pallidus and striatal dopamine induced by intranigrally administered neurotensin (1985) (34)
Dopamine‐Dependent Postnatal Development of Enkephalin and Tachykinin Neurons of Rat Basal Ganglia (1991) (34)
Metabolism of tyramine-3H and octopamine-3H by rat brain. (1969) (33)
ALTERATIONS IN THE NEUROCYTOTOXICITY OF 5,7‐DIHYDROXYTRYPTAMINE BY PHARMACOLOGIC AGENTS IN ADULT AND DEVELOPING RATS * (1978) (33)
Species Differences in Regional Patterns of 3H-8-OH-DPAT and 3H-Zolpidem Binding in the Rat and Human Brain (1998) (33)
202 – INTERACTIONS OF THYROTROPIN RELEASING HORMONE WITH CENTRALLY-ACTING DRUGS (1977) (31)
Comparison of tyrosine hydroxylase and dopamine-Β-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity (1974) (31)
D1 Dopamine Receptor Binding and mRNA Levels Are Not Altered After Neonatal 6‐Hydroxydopamine Treatment: Evidence Against Dopamine‐Mediated Induction of D1 Dopamine Receptors During Postnatal Development (1993) (31)
Thyrotropin-releasing hormone (TRH) and its beta-alanine analogue: potentiation of the anticonvulsant potency of phenobarbital in mice. (1975) (31)
Evidence that respiratory depression by serotonin agonists may be exerted in the central nervous system (1980) (31)
Effects of catecholamine depleting drugs and d-amphetamine on self-stimulation of the substantia nigra and locus coeruleus. (1978) (31)
3-methoxy-4-hydroxyphenylglycol excretion and behavioural changes in rat and monkey after central sympathecomy with 6-hydroxydopamine. (1972) (30)
Augmented sensitivity of D1-dopamine receptors in lateral but not medial striatum after 6-hydroxydopamine-induced lesions in the neonatal rat. (1992) (30)
Contransmitters: differential effects of serotonin (5-HT)-depleting drugs on levels of 5-HT and TRH and their receptors in rat brain and spinal cord (1989) (30)
Evidence that lack of brain dopamine during development can increase the susceptibility for aggression and self-injurious behavior by influencing D1-dopamine receptor function (1990) (30)
Attenuation of the effect of punishment by thyrotropin-releasing hormone: comparisons with chlordiazepoxide. (1980) (30)
Noradrenergic hyperinnervation reduces the density of β-adrenergic receptors in rat cerebellum (1979) (30)
High resolution autoradiographic determination of the topographic distribution of radioactivity in the hippocampal formation after injection of [1-14C]glucose or 2-deoxy[14C]glucose (1986) (30)
Similar effects of ethanol and flumazenil on acquisition of a shuttle‐box avoidance response during withdrawal from chronic ethanol treatment (1993) (29)
A selective ALDH-2 inhibitor reduces anxiety in rats (2009) (29)
Effect of dopaminergic agonists and antagonists on in vivo cyclic nucleotide content: relation of guanosine 3':5'- monophosphate (cGMP) changes in cerebellum to behavior. (1979) (29)
Neuroanatomical characterization of inferior collicular seizure genesis: 2-deoxyglucose and stimulation mapping (1991) (29)
Effects of intracisternal 6-hydroxydopamine treatment on acquisition and performance of rats in a double T-maze. (1974) (29)
Brainstem localization of a thyrotropin-releasing hormone-induced change in respiratory function (1986) (29)
CATECHOLAMINE METABOLISM IN THE DOG: COMPARISON OF INTRAVENOUSLY AND INTRAVENTRICULARLY ADMINISTERED [14C]DOPAMINE AND [3H]NOREPINEPHRINE (1971) (29)
Macrokinetic analysis of blockade of NMDA-gated currents by substituted alcohols, alkanes and ethers (2004) (29)
Thyrotropin releasing hormone (TRH): DOPA potentiation and biogenic amine studies (1975) (28)
Aminophylline may stimulate respiration in rats by activation of dopaminergic receptors. (1981) (28)
Ultrasonic vocalization behavior differs between lines of ethanol-preferring and nonpreferring rats. (1997) (28)
Decreased immunoreactivity of the melanocortin neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) after chronic ethanol exposure in Sprague-Dawley rats. (2008) (28)
Amino acid influences on seizures elicited within the inferior colliculus. (1987) (28)
Changes in the Effect of Isoflurane on N-methyl-d-aspartic Acid-gated Currents in Cultured Cerebral Cortical Neurons with Time in Culture: Evidence for Subunit Specificity (2002) (28)
Effects of ethanol, MK-801, and chlordiazepoxide on locomotor activity in different rat lines: dissociation of locomotor stimulation from ethanol preference. (1994) (27)
Thyrotropin-releasing hormone reversal of ethanol-induced decreases in cerebellar cGMP (1978) (27)
A conflict procedure not requiring deprivation: evidence that chronic ethanol treatment induces tolerance to the anticonflict action of ethanol and chlordiazepoxide. (1989) (27)
Behavioral effects of hypothalamic releasing hormones in animals and men. (1975) (27)
Detection of serotonin receptor transcripts in the developing nervous system (1992) (27)
The Developmental Profile of Seizure Genesis in the Inferior Collicular Cortex of the Rat: Relevance to Human Neonatal Seizures (1992) (27)
Evidence for site specific ethanol actions in the CNS. (1985) (27)
Ontogeny of striatal unit activity and effects of single or repeated haloperidol administration in rats (1985) (27)
Effects of anesthetics and electrical stimulation on nigrostriatal dopaminergic neurons. (1983) (26)
Neonatal destruction of dopaminergic neurons. (1994) (26)
Action of zolpidem on responses to GABA in relation to mRNAs for GABAA receptor alpha subunits within single cells: Evidence for multiple functional GABAA isoreceptors on individual neurons (1997) (26)
Change in brain guanosine 3',5'-monophosphate (cGMP) content by thyrotropin-releasing hormone. (1979) (26)
Enantioselective behavioral effects of threo-methylphenidate in rats (1991) (26)
Bombesin increases dopamine function in rat brain areas (1984) (26)
The neuroanatomical specificity of ethanol action on ligand-gated ion channels: a hypothesis. (1993) (26)
Metabolism of amphetamine by rat brain tissue. (1978) (26)
Effect of central catecholamine alterations on the hypothermic response to 6‐hydroxydopamine in desipramine treated rats (1971) (25)
Effects of a stressor and corticotrophin releasing factor on ethanol deprivation-induced ethanol intake and anxiety-like behavior in alcohol-preferring P rats (2011) (25)
Model for reduced brain dopamine in Lesch‐Nyhan syndrome and the mentally retarded: Neurobiology of neonatal‐6‐hydroxydopamine‐lesioned rats (1995) (25)
Chapter 2 – Chemical Lesioning: Catecholamine Pathways (1977) (24)
Gas chromatographic-mass spectrometric analysis of methylphenidate and p-hydroxymethylphenidate using deuterated internal standards. (1985) (24)
Pharmacologic evaluation of SCH-39166, A-69024, NO-0756, and SCH-23390 in neonatal-6-OHDA-lesioned rats. Further evidence that self-mutilatory behavior induced by L-dopa is related to D1 dopamine receptors. (1992) (24)
Nifedipine Suppresses Self-Injurious Behaviors in Animals (2006) (24)
Differential effects of bilateral dopamine depletion in neonatal and adult rats (1997) (24)
Action of ethanol on responses to nicotine from cerebellar interneurons and medial septal neurons: relationship to methyllycaconitine inhibition of nicotine responses. (1999) (24)
Stimulation-induced release of serotonin. (1968) (24)
Ethanol modulation of gamma-aminobutyric acid (GABA)-mediated inhibition of cerebellar Purkinje neurons: relationship to GABAb receptor input. (2000) (24)
Effects of TRH on central nervous system function. (1981) (23)
Neuroanatomically selective down-regulation of beta adrenergic receptors by chronic imipramine treatment: relationships to the topography of [3H]imipramine and [3H] desipramine binding sites. (1989) (23)
Distribution of [3H]zolpidem binding sites in relation to messenger RNA encoding the alpha 1, beta 2 and gamma 2 subunits of GABAA receptors in rat brain. (1995) (23)
Models of chronic alcohol exposure and dependence. (2012) (22)
Pharmacological modulation of repeated ethanol withdrawal-induced anxiety-like behavior differs in alcohol-preferring P and Sprague–Dawley rats (2005) (22)
Phencyclidine supersensitivity in rats with neonatal dopamine loss (2002) (22)
Interactive role for neurosteroids in ethanol enhancement of gamma-aminobutyric acid-gated currents from dissociated substantia nigra reticulata neurons. (1999) (21)
Early postnatal administration of 5,7-dihydroxytryptamine: Effects on substance P and thyrotropin-releasing hormone neurons and terminals in rat brain (1986) (21)
Selective breeding of 5-HT1A receptor-mediated responses: application to emotion and receptor action (2000) (21)
Ontogeny of tolerance to haloperidol: behavioral and biochemical measures. (1985) (21)
Depression of some drug-induced in vivo changes of cerebellar guanosine 3',5'-monophosphate by control of motor and respiratory responses. (1979) (21)
Simultaneous determination of thioridazine and its S-oxidized and N-demethylated metabolites using high-performance liquid-chromatography on radially compressed silica. (1982) (21)
The Role of Dopamine Receptors in the Neurobehavioral Syndrome Provoked by Activation of L-Type Calcium Channels in Rodents (2006) (21)
Interactions between TRH and ethanol in the medial septum (1986) (20)
Behavioral and prolactin responses to 5-hydroxytrytophan in rats treated during development with 5,7-dihydroxytryptamine (1978) (20)
Chronic dopa treatment: effect on the concentration of norepinephrine in the hearts and brains of rats. (1971) (20)
Serum concentrations of thioridazine, its major metabolites and serum neuroleptic‐like activities in schizophrenics with and without tardive dyskinesia (1982) (20)
Regional differences in the effects of chronic ethanol administration on [3H]zolpidem binding in rat brain. (1995) (20)
Action of ethanol on responses to nicotine from cerebellar Purkinje neurons: relationship to methyllycaconitine (MLA) inhibition of nicotine responses (1999) (20)
Attenuation of the effects of punishment by ethanol: Comparisons with chlordiazepoxide (2004) (20)
Alteration of aminophylline-induced respiratory stimulation by perturbation of biogenic amine systems. (1981) (19)
High resolution autoradiography at the regional topographic level with [14C]2-deoxyglucose and [3H]2-deoxyglucose (1987) (19)
Effect of various 6-hydroxydopamine treatments during development on growth and ingestive behavior (1975) (19)
Neuroanatomical specificity and dose dependence in the time course of imipramine-induced beta adrenergic receptor down-regulation in rat brain. (1994) (18)
Seizure interactions between the inferior collicular cortex and the deep prepiriform cortex (1991) (18)
Neuropeptide Y signaling modulates the expression of ethanol‐induced behavioral sensitization in mice (2012) (18)
Evidence for TNFα action on excitatory and inhibitory neurotransmission in the central amygdala: A brain site influenced by stress (2013) (18)
Effects of apamin and nicotinic acetylcholine receptor antagonists on inferior collicular seizures. (1990) (18)
Lead exposure during infancy permanently increases lithium-induced polydipsia. (1978) (18)
Withdrawal from Chronic Alcohol Induces a Unique CCL2 mRNA Increase in Adolescent But Not Adult Brain--Relationship to Blood Alcohol Levels and Seizures. (2015) (17)
Growth hormone and prolactin secretion in adults and hyperactive children: Relation to methylphenidate serum levels (1981) (16)
Attempted antagonism of adenosine analogue induced depression of respiration (1984) (16)
β-Adrenergic receptor binding in human and rat hypothalamus (1992) (16)
A centrally elicited respiratory stimulant effect by bombesin in the rat. (1985) (16)
Effects of amphetamine derivatives on brain dopamine and noradrenaline (1970) (16)
Effects of catecholamine-depleting drugs and amphetamine on self-stimulation of brain following various 6-hydroxydopamine treatments (1974) (16)
Effects of 2,4,5-trichlorophenoxyacetic acid and quinolinic acid on 5-hydroxy-3-indoleacetic acid transport by the rabbit choroid plexus: pharmacology and electron microscopic cytochemistry. (1987) (16)
Increased consumption but not operant self-administration of ethanol in mice lacking the RIIbeta subunit of protein kinase A. (2006) (16)
An efficient chronic conflict paradigm: Lick suppression by incremental footshock (1983) (15)
Pharmacological evaluation of SCH-12679: evidence for an in vivo antagonism of D1-dopamine receptors. (1990) (15)
Topography of basal glucose utilization in the hippocampus determined with [1-14C]glucose and [6-14C]glucose (1988) (15)
MODULATION OF ADRENAL TYROSINE HYDROXYLASE INDUCTION BY SEROTONIN NERVE FUNCTION (1973) (15)
The role of the inferior collicular cortex in the neonatal rat: sensorimotor modulation. (1991) (15)
Persistent adaptation by chronic alcohol is facilitated by neuroimmune activation linked to stress and CRF. (2016) (15)
Can CRF1 receptor antagonists become antidepressant and/or anxiolytic agents? (2005) (15)
Elevated anxiety-like behavior following ethanol exposure in mutant mice lacking neuropeptide Y (NPY). (2007) (15)
Drug alterations of punished responding after chlordiazepoxide: Possible screen for agents useful in minimal brain dysfunction (1981) (14)
Importance of dopaminergic pathways and other neural systems to behavior and action of psychotropic drugs. (1978) (14)
Topographical assessment of accumulated radioactivity from [14C]2-deoxyglucose and [6-14C]glucose in rat forebrain at different survival periods (1989) (14)
Effects of vagotomy and glossopharyngectomy on respiratory response to dopamine-agonists. (1982) (14)
The role of vagal afferents and carbon dioxide in the respiratory response to thyrotropin-releasing hormone (1985) (14)
Respiratory stimulant effects by TRH into the mesencephalic region in the rat. (1987) (14)
Dopaminergic regulation of proenkephalin-A gene expression in the basal ganglia. (1986) (14)
The Use of Neurotoxins to Lesion Catecholamine-Containing Neurons to Model Clinical Disorders (1998) (14)
Involvement of protein kinase A in ethanol-induced locomotor activity and sensitization (2006) (14)
Relationship of biogenic amines to behavior. (1974) (14)
Methylphenidate affects strategic choice behavior in normal adult humans (1987) (13)
Changes in cerebrospinal fluid homovanillic acid in children with Ondine's curse (1987) (13)
Effect of acute and chronic olanzapine treatment on phencyclidine-induced behavioral sensitization in rats with neonatal dopamine loss (2004) (13)
Cerebellar cGMP varies with motor function and respiratory gas exchange (1978) (13)
Vasopressin and alcohol: a multifaceted relationship (2018) (13)
Octanoic Acid Produces Accumulation of Monoamine Acidic Metabolites in the Brain: Interaction with Organic Anion Transport at the Choroid Plexus (1992) (13)
High activity neurons in the reticular formation of the medulla oblongata: A high-resolution autoradiographic 2-deoxyglucose study (1990) (13)
Role of Monoamine Neural Pathways in d-Amphetamine- and Methylphenidate-Induced Locomotor Activity (1977) (12)
Involvement of brain monoamines in the stimulant and paradoxical inhibitory effects of methylphenidate (1975) (12)
A comparison of behavioral and neurochemical effects of ethanol and chlordiazepoxide. (1980) (12)
Autoradiographic analysis of the in vivo distribution of 3H-imipramine and 3H-desipramine in brain: Comparison to in vitro binding patterns (1991) (12)
Ethanol-induced locomotor stimulation in rats after thyrotropin-releasing hormone. (1984) (12)
Morphological evidence for 6-hydroxydopamine-induced sprouting of noradrenergic neurons in the cerebellum (1978) (12)
A mouse model for chronic pain-induced increase in ethanol consumption (2017) (12)
Effect of ethanol on cyclic nucleotides in vivo: consequences of controlling motor and respiratory changes. (1979) (12)
Age-related differences in anxiety-like behavior and amygdalar CCL2 responsiveness to stress following alcohol withdrawal in male Wistar rats (2016) (12)
Mechanistic and functional divergence between thyrotropin-releasing hormone and RO 15-4513 interactions with ethanol. (1989) (12)
Neurobiology of lead intoxication in the developing rat (1976) (11)
Physiological and behavioral effects of centrally-administered 6-hydroxydopamine in cats. (1974) (11)
The Use of Perinatal 6-Hydroxydopamine to Produce a Rodent Model of Lesch-Nyhan Disease. (2016) (11)
Differential effects of TRH, amphetamine, naloxone, and fenmetozole on ethanol actions: attenuation of the effects of punishment and impairment of aerial righting reflex. (1981) (11)
Cotransmitters: differential effects of serotonin (5-HT)-depleting drugs on levels of 5-HT and TRH and their receptors in rat brain and spinal cord. (1989) (11)
Isoniazid: behavioral and biochemical effects in rhesus monkeys. (1976) (10)
CENTRAL DOPAMINERGIC MODULATION OF THE RESPIRATORY CONTROL SYSTEM (1979) (10)
Cardiovascular changes following DOCA-NaCl or conditioning in 6-hydroxydopamine-treated rats. (1974) (10)
Amygdala arginine vasopressin modulates chronic ethanol withdrawal anxiety-like behavior in the social interaction task. (2019) (10)
Neuroanatomical differences in the rate of beta-adrenergic receptor adaptation after repeated treatment with imipramine. (1993) (10)
ACTIONS OF NEUROTENSIN ON DOPAMINERGIC AND SEROTONERGIC PATHWAYS IN RAT BRAIN (1982) (9)
Changes in apical dendritic structure correlate with sustained ERK1/2 phosphorylation in medial prefrontal cortex of a rat model of dopamine D1 receptor agonist sensitization (2008) (9)
An alternative to animal models of central nervous system disorders: Study of drug mechanisms and disease symptoms in animals (1978) (9)
Effects of TRH, ethanol, and TRH-ethanol combination on activity in rats with altered monoamine content (1985) (9)
Parameters of alteration of pentobarbital response by hypothalamic polypeptides. (1975) (9)
Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats (2004) (9)
Hemophilus influenzae meningitis in the rat: Behavioral, electrophysiological, and biochemical consequences (1987) (9)
Action of Ethanol and Zolpidem on γ‐Aminobutyric Acid Responses from Cerebellar Purkinje Neurons: Relationship to β‐Adrenergic Receptor Input (1998) (8)
Effects of different monoamine oxidase inhibitors on respiratory activity in rats with chronically impaired central serotonergic function. (2009) (8)
Functional activity patterns in the forebrain of swimming rats: a 5 min 2-deoxyglucose study (1989) (7)
Serotonin turnover and supersensitivity after neonatal 5,7-dihydroxytryptamine (1985) (7)
Similarities in the central actions of GABA-mimetic drugs:. and ethanol (1979) (7)
Altered activity patterns following neonatal 6-hydroxydopamine lesions to dopaminergic neurons: effect of SKF-38393 (1994) (7)
'Supersensitivity' of dopamine systems: Comparisons between haloperidol withdrawal, intracisternal (IC) and unilateral (UNI) 6-hydroxydopamine (OHDA) treatments (1981) (7)
Effect of Olanzapine on Functional Responses from Sensitized D1-Dopamine Receptors in Rats with Neonatal Dopamine Loss (2001) (7)
ANTAGONISM OF 2 CHLOROADENOSINE INDUCED RESPIRATORY DEPRESSION BY AMINOPHYLLINE AND NALOXONE (1982) (7)
Brain-Behavioral Effects of Hypothalamic Releasing Hormones (1975) (7)
Cardiovascular interactions between acutely administered reserpine and mephentermine. (1965) (7)
Synthesis of deuterium‐labelled methylphenidate, p‐hydroxymethylphenidate, ritalinic acid and p‐hydroxyritalinic acid (1982) (6)
6-Hydroxydopamine Lesioning of Dopamine Neurons in Neonatal and Adult Rats Induces Age-Dependent Consequences (2014) (6)
Differential effects of single versus repeated minocycline administration—Lack of significant interaction with chronic alcohol history (2018) (6)
Enhanced muscimol-induced behavioral responses after 6-OHDA lesions: relevance to susceptibility for self-mutilation behavior in neonatally lesioned rats (2004) (6)
Neural adaptation in response to chronic imipramine and electroconvulsive shock: evidence for separate mechanisms. (1991) (6)
A role for dopamine in the psychopharmacology of electrical self-stimulation. (1975) (6)
Enhanced behavioral depressant effects of reserpine and α-methyltyrosine after 6-hydroxydopamine treatment (2004) (6)
Thyroid-Imipramine Interaction: Clinical Results and Basic Mechanism (1971) (6)
Acute ergotropic response induced by reserpine and mephentermine. (1966) (6)
Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments (1973) (6)
The effects of thyrotropin-releasing hormone (TRH) and other drugs on the actions of alcohol. (1980) (5)
Factors mediating alcohol craving and relapse: stress, compulsivity, and genetics. (2005) (5)
Simultaneous determination of thioridazine and its sulfoxidized metabolites by HPLC: Use in clinical and preclinical metabolic studies (1981) (5)
Effects of chronic electrode implantation on dopaminergic neurons in vivo (1986) (5)
Comparative effects of stressors on behavioral and neuroimmune responses of fawn-hooded (FH/Wjd) and Wistar rats: Implications for models of depression (2018) (5)
Altered respiratory response to substance P in capsaicin‐treated rats (1985) (5)
Evidence for a role of dopamine in amphetamine induced motor activity and stereotypy (1973) (5)
Effect of monoamine oxidase inhibitors on the disposition of intracisternally administered metaraminol-3H. (1970) (5)
67 – The Effect of Ethanol on Ion Channels in the Brain: A New Look (2004) (5)
Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine (1980) (5)
Effects of intracisternal neurotensin, β-endorphin or bombesin on ethanol-induced sedation and hypothermia (1980) (4)
Unilateral kindling of the inferior collicular cortex does not transfer to the contralateral seizure sensitive site or alter [3H]flunitrazepam and [35S]TBPS binding (1991) (4)
A role for dopamine in the psychopharmacology of electrical self-stimulation of the lateral hypothalamus, substantia nigra, and locus coeruleus. (1975) (4)
An evaluation of the selectivity of fenmetozole (DH-524) reversal of ethanol-induced changes in central nervous system function (2004) (4)
Phenotyping CCL2 Containing Central Amygdala Neurons Controlling Alcohol Withdrawal-Induced Anxiety (2020) (4)
Use of 6-hydroxydopamine to deplete brain catecholamines in the rhesus monkey: effects on urinary catecholamine metabolites and behavior (2004) (4)
IN VIVO CYCLIC NUCLEOTIDE CONTENT: EFFECTS OF DOPAMINERGIC AGONISTS AND ANTAGONISTS (1979) (4)
Effect of 2-chloroadenosine (2CA) on respiratory activity (1982) (4)
Hypothalamic releasing hormones and catecholamines: A new interface (1974) (3)
Proceedings: Evidence for a dopaminergic involvement in the maintenance of self-stimulation. (1974) (3)
Action of ethanol and zolpidem on gamma-aminobutyric acid responses from cerebellar Purkinje neurons: relationship to beta-adrenergic receptor input. (1998) (3)
The effect of triiodothyronine on the disposition and actions of imipramine (2004) (3)
L-DOPA-induced self-biting in rats treated with 6-hydroxydopamine (6-OHDA) as neonates: Model of self-mutilation observed in the Lesch-Nyhan syndrome (1984) (3)
GABAergic modulation of inferior colliculus excitability: role in the ethanol withdrawal audiogenic seizures. Erratum and additional information. (1986) (3)
RELATIONSHIP OF BIOGENIC AMINES TO BEHAVIOR (1975) (3)
The Use of Neurotoxins to Lesion Catecholamine-Containing Neurons to Model Clinical Disorders: Approach for Defining Adaptive Neural Mechanisms and Role of Neurotrophic Factors in Brain (1997) (3)
The Role of Protein Kinase A in the Ethanol-induced Increase in Spontaneous GABA Release onto Cerebellum Purkinje Neurons (2008) (3)
The Neurochemical Basis of Symptoms in the Lesch-Nyhan Syndrome (1987) (3)
Effects of various drugs on the actions of 5,7 dihydroxytryptamine (1974) (3)
Age-dependent reduction of brain dopamine: Relationship to self-injurious behavior. (2002) (2)
Behavioral and biochemical studies of the scopolamine-induced reversal of neuroleptic activity (2004) (2)
Reduced forebrain norepinephrine in rhesus monkeys made obese by hypothalamic lesions (1980) (2)
CHANGES IN Meeting Abstracts AFTER THYROIDECTOHY AND PARATHYROIDECTOMY (1984) (2)
Electrophysiological assessment of dopamine receptor subtypes. (1986) (2)
Dopamine antagonists do not block testosterone-induced decrease in luteinizing hormone (1982) (2)
Principles of pharmacology: basic concepts (2013) (2)
Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain. (1974) (2)
Antagonism of ethanol-induced decrease in LH by para-chlorophenylalanine: Lack of correlation with altered serotonergic mechanisms (1981) (2)
Importance of the Locus coeruleus and involvement of α-adrenergic receptors in the post-decapitation reflex in the rat (2004) (2)
Erratum: Interactive role for neurosteroids in ethanol enhancement of γ-aminobutyric acid-gated currents from dissociated substantia nigra reticulata neurons (Journal of Pharmacology and Experimental Therapeutics (1999) 291 (1054-1059)) (2000) (1)
Pharmacology of hydroxylated metabolites of methylphenidate (1981) (1)
Evidence for a role of dopamine (DA) in electrical self stimulation of brain (1973) (1)
Lead enhancement of lithium-induced polydipsia. (1979) (1)
SYNTHESIS AND PHARMACOLOGY OF HYDROXYLATED METABOLITES OF METHYL PHENIDATE (1982) (1)
Drugs and the Synapse (2001) (1)
NMDAR1 SPLICING ALTERS THE EFFECTS OF ISOFLURANE ON NMDA RECEPTORS: THE ROLE OF THE EXON 5 INSERT (1998) (1)
Systemically-administered apomorphine increases and microiontophoretically-applied dopamine decreases neuronal activity in rodent globus pallidus (1985) (1)
Increased Consumption but not Operant Self-Administration of Ethanol in Mice Lacking the RII β Subunit of Protein Kinase A (PKA) (2008) (1)
P.5.039 Acamprosate counteracts anxiety-like behaviorinduced by multiple ethanol withdrawals (2004) (1)
Differential classical aversive conditioning in 'centrally sympathectomized' rats and cats (1974) (1)
Interaction of thyrotropin releasing hormone with various centrally acting depressants (1974) (1)
A role for dopamine in the stimulant effects of amphetamine on locus coeruleus self stimulation (1974) (1)
Topography of basal glucose utilization in rat thalamus and hypothalamus determined with (1-14C)-glucose (2004) (1)
Evidence for involvement of brain serotonin in the actions of amphetamine and other phenylethylamine derivatives (1974) (1)
Involvement of brain dopamine in growth and consummatory deficits observed after administration of 6 hydroxydopamine (6 OHDA) to immature rats (1973) (1)
Relatively selective D-1 dopamine receptor supersensitivity after neonatal-6-OHDA-treatment (1985) (1)
Potentiation of drug-initiated adrenal tyrosine hydroxylase induction by diazepam (2004) (1)
Faculty of 1000 evaluation for Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. (2009) (0)
A724 ENHANCED EXPRESSION OF PROTO-ONCOGENE C-FOS PROTEIN IN RATS GIVEN KETAMINE (1990) (0)
HORMONES IN THE TREATMENT OF NERVOUS AND MENTAL DISEASE: PRESENT STATUS AND DEVELOPMENT (1978) (0)
SELECTIVE PROPHYLACTIC EFFECT OF ACAMPROSATE AND BACLOFEN IN COUNTERACTING ANXIETY AFTER MULTIPLE ETHANOL WITHDRAWALS. (2004) (0)
Monoaminergic mechanisms involved in the post-decapitation reflex (1978) (0)
Changes in the Effect of Isoﬂurane on N -methyl- D -aspartic Acid-gated Currents in Cultured Cerebral Cortical Neurons with Time in Culture Evidence for Subunit Speciﬁcity (2002) (0)
Evidence against dopaminergic mediation of ethanol-induced depression of plasma luteinizing hormone (LH) in castrated rats (1978) (0)
Contents Vol. 28, 2006 (2006) (0)
Further evidence of central serotoninergic modulation of respiratory control in the rat (1979) (0)
Faculty Opinions recommendation of PKCepsilon regulates behavioral sensitivity, binding and tolerance to the CB1 receptor agonist WIN55,212-2. (2009) (0)
NEURONAL AND BEHAVIORAL PLASTICITY AFTER NORADRENERGIC LESIONS IN DEVELOPING RAT (1979) (0)
Cholinergic interactions with the analeptic like activity of thyrotropin releasing hormone (1975) (0)
50. AAV-Mediated Expression and Secretion of ADNF-9 Protects Substantia Nigra Neurons from 6-OHDA Damage (2004) (0)
Rapid elevation of TRH-like immunoreactivity (TRH-LI) by combined electroconvulsive shock (ECS) and imipramine (IMI) (1985) (0)
Comparison of the effects of 1,3-butanediol and ethanol (1980) (0)
Faculty Opinions recommendation of Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons. (2008) (0)
Neurobiology of Supersensitive D1 and D2-Dopamine Receptors after 6-Hydroxydopamine Lesions (1988) (0)
Brain neurotransmitter and high-energy phosphate concentration after combined hypoxia and hypotension. (1981) (0)
Wild running seizures elicited by electrical stimulation of the inferior colliculus are marked by inferior colliculus afterdischarge which can spread to the cortex (1984) (0)
Proceedings: Relationship of catecholamine neural systems to the behavioral alterations produced by 6-hydroxy-dopamine administration into brain. (1974) (0)
The Role of Neuropeptide Y (NPY) In Uncontrolled Alcohol Drinking and Relapse Behavior Resulting From Exposure to Stressful Events (2007) (0)
Effects ofamphetamine derivatives onbrain dopamine andnoradrenaline (1970) (0)
GENERAL DISCUSSION (1978) (0)
Opposite alterations in cerebrospinal fluid uridine after severe cerebral ischemia or intrathecal blood injection (1990) (0)
BRAIN SEROTONIN AND THE RESPONSE TO HEMORRHAGE (1980) (0)
Faculty Opinions recommendation of Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress. (2008) (0)
Comparison of Concentration-Response and Macrokinetic Variables across Anesthetics and Alcohols: [2002][A-771] (2002) (0)
Increased cGMP content in striatum and cerebellum after administration of d-amphetamine and apomorphine (1978) (0)
Faculty Opinions recommendation of Empathy and pro-social behavior in rats. (2011) (0)
989 – ACUTE ANTAGONISTS OF ETHANOL ACTIONS: DIFFERENTIAL EFFECTS OF THYROTROPIN-RELEASING HORMONE AND OTHER PUTATIVE ANTAGONISTS (1978) (0)
KETAMINE ANESTHESIA IS ANTAGONIZED BY CNS DOPAMINE NEURONS (1992) (0)
Enhanced sensitivity to the behavioral depressant effects of alpha methyltyrosine (AMT) following 6 hydroxydopamine (6 OHDA) treatments: involvement of brain dopamine (DA) (1973) (0)
Age-related differences in anxiety-like behavior and amygdalar CCL2 responsiveness to stress following alcohol withdrawal in male Wistar rats (2016) (0)
Intracisternal treatment with 5,7-dihydroxytryptamine enhances 5-HTP-induced release of prolactin (1978) (0)
Postsynaptic Currents in Spinal Motoneurons Ethanol Dual Modulatory Actions on Spontaneous (2015) (0)
Comparisons of bupropion, amphetamine and methylphenidate on pre-synaptic dopamine metabolism (1981) (0)
Age related differences in anxiety-like behavior and amygdalar CCL2 responsiveness to stress following alcohol withdrawal (2017) (0)
Antagonism of ethanol sedation with thyrotropin releasing hormone (1974) (0)
_tdation. It is tl METABOLISM OF INTRACISTERNALLY ADMINISTERED in_themeta- ( SEROTONIN 1N RAT BRAIN (1978) (0)
Faculty Opinions recommendation of Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. (2009) (0)
Biochemical pharmacology of brain amine mechanisms. (1975) (0)
Homotypic serotonergic reinnervation of the hippocampus following neonatal 5,7-DHT treatment (1983) (0)
Antagonism of the ethanol-induced fall in cerebellar guanosine cyclic-3',5'-monophosphate by thyrotropin-releasing hormone (1977) (0)
Room D, 10/17/2000 2: 00 PM - 4: 00 PM (PS) Differential Sensitivity of GABA and NMDA Receptors to Isoflurane A-781 (2000) (0)
Changes in brain cyclic-GMP and cyclic-AMP as a function of arterial oxygen and carbon dioxide tension (1978) (0)
Subject Index Vol. 28, 2006 (2006) (0)
Faculty Opinions recommendation of Neuritin produces antidepressant actions and blocks the neuronal and behavioral deficits caused by chronic stress. (2012) (0)
PHARMACOLOGICAL REVERSAL OF CYCLED WITHDRAWAL- OR STRESS-SENSITIZED WITHRAWAL ANXIETY AND ENHANCED ETHANOL DRINKING. (2004) (0)
Biochemical and behavioral effects produced by 5,7 dihydroxy tryptamine (5,7 DHT) when administered to rats during development (1977) (0)
CHANGES IN RESPIRATION AFTER THYROIDECTOHY AND PARATHYROIDECTOMY (1984) (0)
Possible indolaminergic involvement in ethanol's effect on LH (1980) (0)
Vasopressin and alcohol: a multifaceted relationship (2018) (0)
Stimulation of respiration by thyropropin releasing hormone (TRH) (1981) (0)
Effects of Thyrotropin-Releasing Hormone (TRH) on the Actions of Pentobarbital and Other Centrally Acting Drugs1 (2010) (0)
Faculty Opinions recommendation of Distinct extended amygdala circuits for divergent motivational states. (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With George R. Breese?

George R. Breese is affiliated with the following schools:

George R. Breese's Academic­Influence.com Rankings

George R. Breese's Degrees

Why Is George R. Breese Influential?

George R. Breese's Published Works

Published Works

What Schools Are Affiliated With George R. Breese?

George R. Breese's AcademicInfluence.com Rankings